A previous study found that certain substances can prevent or treat prostatic cancer by inhibition of CD84 mRNA (76), suggesting that further exploration of the role of CD84 in lung cancer may guide the identification of novel therapeutic targets. This evidence concerns the gene CD84 and prostate cancer.